Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor

Radiation Research

Volumn 148, Issue 3, 1997, Pages 235-239

  Shibuya, Kiyoshi ^a   Cherian, M George ^b   Satoh, Masahiko ^c  

^a KITASATO INSTITUTE   (Japan)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN; PROPARGYLGLYCINE; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CELL DAMAGE; CONTROLLED STUDY; ENZYME INHIBITION; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; TREATMENT PLANNING;

ALKYNES; ANIMALS; ENZYME INHIBITORS; FIBROSARCOMA; GLYCINE; MALE; METALLOTHIONEIN; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; RADIOTHERAPY DOSAGE; X-RAYS; ZINC SULFATE;

ANIMALIA; MURINAE;

EID: 0030856087     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579607     Document Type: Article

References (35)

1. J. Matsubara, T. Shida, K. Ishioka, S. Egawa, T. Inada and K. Machida, Protective effect of zinc against lethality in irradiated mice. Environ. Res. 41, 558-567 (1986).
2. J. Matsubara, Y. Tajima and M. Karasawa, Metallothionein induction as a potent means of radiation protection in mice. Radiat. Res. 111, 267-275 (1987).
3. S. Kobayashi, M. Kasuya, Y. Ishii, K. Sasaki, N. Suzuki, H. Nishimura, N. Nishimura, C. Tohyama and M. Itoi, Effect of zinc on rat X-ray cataract. J. Eye 6, 1249-1252 (1989).
4. M. Satoh, N. Miura, A. Naganuma, N. Matsuzaki, E. Kawamura and N. Imura, Prevention of adverse effects of γ-ray irradiation by metallothionein induction by bismuth subnitrate in mice. Eur. J. Cancer Clin. Oncol. 25, 1727-1731 (1989).
5. J. H. R. Kagi and A. Schaffer, Biochemistry of metallothionein. Biochemistry 27, 8509-8515 (1988).
6. A. Bakka, A. S. Jonsen, L. Endresen and H. E. Rugstad, Radioresistance in cells with high content of metallothionein. Experientia 38, 381-383(1982).
7. M. J. Renan and P. I. Dowman, Increased radioresistance of tumor cells exposed to metallothionein-inducing agents. Radiat. Res. 120, 442-455 (1989).
8. A gene protects Chinese hamster ovary cells from killing by alkylating agents. Proc. Natl. Acad. Sci. USA 87, 2710-2714 (1990).
9. H. Lohrer and T. Robson, Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis 10, 2279-2284 (1989).
10. A. Naganuma, M. Satoh and N. Imura, Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res. 47, 983-987 (1987).
11. M. Satoh, A. Naganuma and N. Imura, Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination. Cancer Chemother. Pharmcol 21, 176-178 (1988).
12. Y. Kondo, M. Satoh, N. Imura and M. Akimoto, Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother. Pharmacol. 29, 19-23 (1991).
13. Y. Kondo, M. Satoh, N. Imura and M. Akimoto, Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of csi-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res. 12, 2303-2308 (1992).
14. A. Naganuma, M. Satoh and N. Imura, Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn. J. Cancer Res. 79, 406-411 (1988).
15. M. Satoh, A. Naganuma and N. Imura, Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heart. Toxicology 53, 231-237 (1988).
16. N. Imura, M. Satoh and A. Naganuma, Possible application of metallothionein in cancer therapy. In Metallothionein in Biology and Medicine (C. D. Klaassen and K. T. Suzuki, Eds.), pp. 375-382. CRC Press, Boca Raton, FL, 1992.
17. M. Satoh, T. Tsuchiya, Y. Kumada, A. Naganuma and N. Imura, Protection against lethal toxicity of various anticancer drugs by preinduction of metallothionein synthesis in mice. J. Trace Elem. Exp. Med. 6, 41-44 (1993).
18. A. Basu and J. S. Lazo, A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol. Lett. 50, 123-135 (1990).
19. M. Satoh, M. G. Cherian, N. Imura and H. Shimizu, Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res. 54, 5255-5257 (1994).
20. M. Satoh, D. M. Kloth, S. A. Kadhim, J. L. Chin, A. Naganuma, N. Imura and M. G. Cherian, Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res. 53, 1829-1832 (1993).
21. J. U. Chapman and C. J. Gillespie, Radiation-induced events and their time scale in mammalian cells. In Advances in Radiation Biology, Vol. 9 (J. T. Lett and H. Adler, Eds.), pp. 143-198. Academic Press, New York, 1981.
22. M. Sato and I. Bremner, Oxygen free radicals and metallothionein. Free Radicals Biol. Med. 14, 325-337 (1993).
23. F. N. Kotosonis and C. D. Klaassen, Comparison of methods for estimating hepatic metallothionein in rats. Toxicol. Appl. Pharmacol 42, 583-588 (1977).
24. D. Banerjee, S. Onosaka and M. G. Cherian, Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 24, 95-105 (1982).
25. M. G. Cherian, The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect. 102, 131-135 (1994).
26. S. L. Kelley, A. Basu, B. A. Teicher, M. P. Hacker, D. H. Hamer and J. S. Lazo, Overexpression of metallothionein confers resistance to anticancer drugs. Science 241, 1813-1815 (1988).
27. K. Kasahara, Y. Fujiwara, K. Nishino, T. Ohmori, Y. Sugimoto, K. Komiya, T. Matuda and N. Saijor, Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res. 51, 3237-3242 (1991).
28. J. Koropatnick, D. M. Kloth, S. Kadhim, J. L. Chin and M. G. Cherian, Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line. J. Pharmacol. Exp. Ther. 275, 1681-1687 (1995).
29. W. W. Nagel and B. L. Vallee, Cell cycle regulation of metallothionein in human colonic cancer cells. Proc. Natl. Acad. Sci. USA 92, 579-583 (1995).
30. L. Endresen, L. Schjerven and H. E. Rugstad, Tumors from a cell strain with a high content of metallothionein show enhanced resistance against cis-dichlorodiammineplatinum. Acta Pharmacol. Toxicol. 55, 183-187 (1984).
31. C. L. Greenstock, C. P. Jinot, R. P. Whitehouse and M. D. Sargent, DNA radiation damage and its modification by metallothionein. Free Radical Res. Commun. 2, 4-6 (1987).
32. L. Cai, J. Koropatnick and M. G. Cherian, Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem. Biol. Interact. 96, 143-155 (1995).
33. K. Shibuya, M. Satoh, M. Muraoka, Y. Watanabe, M. Oida and H. Shimizu, Induction of metallothionein synthesis in transplanted murine tumors by X irradiation. Radiat. Res. 143, 54-57 (1995).
34. H. Eichholtz-Wirth, G. Reidel and B. Hietel, Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content. Br. J. Cancer 67, 1001-1006 (1993).
35. K. R. Gallant and M. G. Cherian, Metabolic changes in glutathione and metallothionein in newborn rat liver. J. Pharmacol. Exp. Ther. 249, 631-637 (1989).